[TNGX] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[TNGX] Tango Therapeutics, Inc.
Announcement Date
08-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -7.50%
YoY- 20.99%
Quarter Report
TNGX's Result
TNGX's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 19,875 6,471 5,431 10,732 14,598 5,766 6,411 112.75%
PBT -25,486 -37,874 -30,716 -22,240 -20,646 -28,008 -29,009 -8.27%
Tax 65 40 47 23 64 -2,278 51 17.56%
NP -25,551 -37,914 -30,763 -22,263 -20,710 -25,730 -29,060 -8.22%
Tax Rate - - - - - - - -
Total Cost 45,426 44,385 36,194 32,995 35,308 31,496 35,471 17.94%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -128.56 -585.91 -566.43 -207.45 -141.87 -446.24 -453.28 -56.86%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.24 -0.35 -0.32 -0.23 -0.23 -0.29 -0.33 -19.14%
EPS Diluted -0.24 -0.35 -0.32 -0.23 -0.23 -0.29 -0.33 -19.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.